Consistency of Return to Normal Function, Productivity, and Satisfaction Following Migraine Attacks Treated With Sumatriptan/Naproxen Sodium Combination-Reference-Cited by-同舟云学术

Consistency of Return to Normal Function, Productivity, and Satisfaction Following Migraine Attacks Treated With Sumatriptan/Naproxen Sodium Combination

Published:2013-09-19 Issue:4 Volume:54 Page:640-654
ISSN:0017-8748
Container-title:Headache: The Journal of Head and Face Pain
language:en
Short-container-title:Headache: The Journal of Head and Face Pain

Author:

Landy Stephen H.¹,Cady Roger K.²,Nelsen Andrew³,White Jonathan³,Runken M. Chris³

Affiliation:

1. Wesley Neurology Clinic; Memphis TN USA

2. Headache Care Center; Springfield MO USA

3. GlaxoSmithKline; Research Triangle Park NC USA

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/head.12214/fullpdf

Reference53 articles.

1. Burden of migraine: Societal costs and therapeutic opportunities;Lipton;Neurology,1997

2. Prevalence and burden of migraine in the United States: Data from the American Migraine Study II;Lipton;Headache,2001

3. What do patients with migraine want from acute migraine treatment?;Lipton;Headache,2002

4. Headache recurrence as a criterion for assessing efficacy of triptans: A perspective;Aurora;Headache,2002

5. Triptans (serotonin, 5-HT1B/1D agonists) in migraine: Detailed results and methods of a meta-analysis of 53 trials;Ferrari;Cephalalgia,2002

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The 5-HT1B and 5-HT1D agonists in acute migraine therapy: Ergotamine, dihydroergotamine, and the triptans;Handbook of Clinical Neurology;2024

2. Evaluating therapeutic benefits of ubrogepant via latent class models: A post hoc exploratory analysis of the ACHIEVE I and ACHIEVE II trials;Headache: The Journal of Head and Face Pain;2023-10-24

3. Measuring, Analyzing, and Presenting Work Productivity Loss in Randomized Controlled Trials: A Scoping Review;Value in Health;2023-01

4. Ubrogepant, an Acute Treatment for Migraine, Improved Patient‐Reported Functional Disability and Satisfaction in 2 Single‐Attack Phase 3 Randomized Trials, ACHIEVE I and II;Headache: The Journal of Head and Face Pain;2020-04

5. Serotonin receptor agonists in the acute treatment of migraine: a review on their therapeutic potential;Journal of Pain Research;2018-03